skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar solo
Refinado por: colección: HighWire Press (Free Journals) eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
Material Type:
Artículo 		Añadir a Mi Portal

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Charles, Pierre ; Terrier, Benjamin ; Perrodeau, Élodie ; Cohen, Pascal ; Faguer, Stanislas ; Huart, Antoine ; Hamidou, Mohamed ; Agard, Christian ; Bonnotte, Bernard ; Samson, Maxime ; Karras, Alexandre ; Jourde-Chiche, Noémie ; Lifermann, François ; Gobert, Pierre ; Hanrotel-Saliou, Catherine ; Godmer, Pascal ; Martin-Silva, Nicolas ; Pugnet, Grégory ; Matignon, Marie ; Aumaitre, Olivier ; Viallard, Jean-François ; Maurier, François ; Meaux-Ruault, Nadine ; Rivière, Sophie ; Sibilia, Jean ; Puéchal, Xavier ; Ravaud, Philippe ; Mouthon, Luc ; Guillevin, Loïc

Annals of the rheumatic diseases, 2018-08, Vol.77 (8), p.1143-1149 [Revista revisada por pares]

England: BMJ Publishing Group LTD

Texto completo disponible

Citas Citado por
2
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
Material Type:
Artículo 		Añadir a Mi Portal

Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study

de Vos, S. ; Swinnen, L.J. ; Wang, D. ; Reid, E. ; Fowler, N. ; Cordero, J. ; Dunbar, M. ; Enschede, S.H. ; Nolan, C. ; Petrich, A.M. ; Ross, J.A. ; Salem, A.H. ; Verdugo, M. ; Agarwal, S. ; Zhou, L. ; Kozloff, M. ; Nastoupil, L.J. ; Flowers, C.R.

Annals of oncology, 2018-09, Vol.29 (9), p.1932-1938 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

Citas Citado por
3
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis
Material Type:
Artículo 		Añadir a Mi Portal

A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis

Pepper, Ruth J ; McAdoo, Stephen P ; Moran, Sarah M ; Kelly, Dearbhla ; Scott, Jennifer ; Hamour, Sally ; Burns, Aine ; Griffith, Megan ; Galliford, Jack ; Levy, Jeremy B ; Cairns, Thomas D ; Gopaluni, Seerapani ; Jones, Rachel B ; Jayne, David ; Little, Mark A ; Pusey, Charles D ; Salama, Alan D

Rheumatology (Oxford, England), 2019-02, Vol.58 (2), p.260-268 [Revista revisada por pares]

England: Oxford University Press

Texto completo disponible

Citas Citado por
4
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
Material Type:
Artículo 		Añadir a Mi Portal

Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab

Rougé, Lionel ; Chiang, Nancy ; Steffek, Micah ; Kugel, Christine ; Croll, Tristan I ; Tam, Christine ; Estevez, Alberto ; Arthur, Christopher P ; Koth, Christopher M ; Ciferri, Claudio ; Kraft, Edward ; Payandeh, Jian ; Nakamura, Gerald ; Koerber, James T ; Rohou, Alexis

Science (American Association for the Advancement of Science), 2020-03, Vol.367 (6483), p.1224-1230 [Revista revisada por pares]

United States: The American Association for the Advancement of Science

Texto completo disponible

Citas Citado por
5
A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis
A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis
Material Type:
Artículo 		Añadir a Mi Portal

A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis

Yoo, Dae Hyun ; Suh, Chang-Hee ; Shim, Seung Cheol ; Jeka, Slawomir ; Cons-Molina, Francisco Fidencio ; Hrycaj, Pawel ; Wiland, Piotr ; Lee, Eun Young ; Medina-Rodriguez, Francisco G ; Shesternya, Pavel ; Radominski, Sebastiao ; Stanislav, Marina ; Kovalenko, Volodymyr ; Sheen, Dong Hyuk ; Myasoutova, Leysan ; Lim, Mie Jin ; Choe, Jung-Yoon ; Lee, Sang Joon ; Lee, Sung Young ; Kwon, Taek Sang ; Park, Won

Annals of the rheumatic diseases, 2017-03, Vol.76 (3), p.566-570 [Revista revisada por pares]

England: BMJ Publishing Group LTD

Texto completo disponible

Citas Citado por
6
Infection incidence, timing and dose dependency in rheumatoid arthritis patients treated with rituximab: a retrospective cohort study
Infection incidence, timing and dose dependency in rheumatoid arthritis patients treated with rituximab: a retrospective cohort study
Material Type:
Artículo 		Añadir a Mi Portal

Infection incidence, timing and dose dependency in rheumatoid arthritis patients treated with rituximab: a retrospective cohort study

Veeken, Lara D ; Opdam, Merel A A ; Verhoef, Lise M ; Popa, Calin ; van Crevel, Reinout ; den Broeder, Alfons A

Rheumatology (Oxford, England), 2024-05, Vol.63 (5), p.1246-1250 [Revista revisada por pares]

England

Texto completo disponible

Citas Citado por
7
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report
Material Type:
Artículo 		Añadir a Mi Portal

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report

Tout, Mira ; Casasnovas, Olivier ; Meignan, Michel ; Lamy, Thierry ; Morschhauser, Franck ; Salles, Gilles ; Gyan, Emmanuel ; Haioun, Corinne ; Mercier, Mélanie ; Feugier, Pierre ; Boussetta, Sami ; Paintaud, Gilles ; Ternant, David ; Cartron, Guillaume

Blood, 2017-05, Vol.129 (19), p.2616-2623 [Revista revisada por pares]

United States: Elsevier Inc

Texto completo disponible

Citas Citado por
8
The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation
The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation
Material Type:
Artículo 		Añadir a Mi Portal

The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation

Nakamura, Akito ; Grossman, Stephen ; Song, Keli ; Xega, Kristina ; Zhang, Yuhong ; Cvet, Donna ; Berger, Allison ; Shapiro, Gary ; Huszar, Dennis

Blood, 2022-05, Vol.139 (18), p.2770-2781 [Revista revisada por pares]

United States: Elsevier Inc

Texto completo disponible

Citas Citado por
9
Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)
Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)
Material Type:
Artículo 		Añadir a Mi Portal

Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)

Ghesquieres, H. ; Chevrier, M. ; Laadhari, M. ; Chinot, O. ; Choquet, S. ; Moluçon-Chabrot, C. ; Beauchesne, P. ; Gressin, R. ; Morschhauser, F. ; Schmitt, A. ; Gyan, E. ; Hoang-Xuan, K. ; Nicolas-Virelizier, E. ; Cassoux, N. ; Touitou, V. ; Le Garff-Tavernier, M. ; Savignoni, A. ; Turbiez, I. ; Soumelis, V. ; Houillier, C. ; Soussain, C.

Annals of oncology, 2019-04, Vol.30 (4), p.621-628 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

Citas Citado por
10
Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models
Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models
Material Type:
Artículo 		Añadir a Mi Portal

Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models

McClure, Mark E ; Zhu, Yajing ; Smith, Rona M ; Gopaluni, Seerapani ; Tieu, Joanna ; Pope, Tasneem ; Kristensen, Karl Emil ; Jayne, David R W ; Barrett, Jessica ; Jones, Rachel B

Rheumatology (Oxford, England), 2021-03, Vol.60 (3), p.1491-1501 [Revista revisada por pares]

England: Oxford University Press

Texto completo disponible

Citas Citado por
Resultados 1 2 3 4 5 next page

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Mostrar solo

  1. Recursos en línea (2.919)
  2. Revistas arbitradas (2.887)

Refinar mis resultados

Tipo de Recurso 

  1. Artículos  (2.819)
  2. Actas de Congreso  (113)
  3. Más opciones open sub menu

Fecha de Publicación 

De Hasta
Refinar
  1. Antes de2001  (28)
  2. 2001Hasta2005  (246)
  3. 2006Hasta2010  (523)
  4. 2011Hasta2016  (664)
  5. Después de 2016  (1.472)
  6. Más opciones open sub menu

Idioma 

  1. Inglés  (2.931)
  2. Japonés  (363)
  3. Ruso  (3)
  4. Noruego  (2)
  5. Más opciones open sub menu

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora